What is the ALLO stock price prediction for next 2 weeks?

According to our price prediction algorithm,Allogene Therapeutics, Inc. (ALLO) price will be around $3.02 in the next 2 weeks. This means it will increase by 20.708000000000002 from the last closing price. This prediction may vary from other time period filters for ALLO stock.

What can be the highest Possible price of ALLO stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ALLO can achieve the highest price of $3.18 which is 27.21002281886372 higher than last closing price. This prediction may vary from other time period filters for ALLO stock.

What can be the lowest Possible price of ALLO stock in next 2 weeks?

As per the forecast and algorithmic analysis, ALLO stock price can be as low as $2.84 which is 13.547719188546967 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for ALLO stock.

Will ALLO stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that ALLO stock will gain20.708000000000002 in the next 2 weeks. This prediction may vary from other time period filters for ALLO stock.

What is ALLO stock last closing price?

Last closing price of ALLO stock was $2.50.

What is ALLO stock price prediction?

ALLO stock price prediction means predicting the future closing prices of ALLO stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ALLO stock in a certain time period.

How we predict ALLO stock future prices?

If you are searching for ALLO stock forecast, analysis or price prediction, then you might be wondering what Allogene Therapeutics, Inc. (ALLO) will do in the future. Our ALLO price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ALLO price prediction will likely answer most of your questions.

How frequent we update ALLO stock predictions?

We are updating the forecasts for the ALLO stock on daily basis.

Is using ML forecasting for ALLO stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ALLO stock same for all the time periods?

No, the prediction for ALLO stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Allogene Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$2.509.17%Since 2 Weeks

Predicted Price$3.0220.71%For 2 Weeks

Upper Predicted Price$3.1827.21%For 2 Weeks

Lower Predicted Price$2.8413.55%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ALLO will rise by +20.71% over the next 2 Weeks and hit $3.02 by Monday, March 23, 2026. In that time frame, ALLO's share price is expected to range between $2.84 and $3.18.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Mar 23, 2026	2.84	3.02	3.18
Mar 20, 2026	2.79	2.97	3.15
Mar 19, 2026	2.73	2.89	3.07
Mar 18, 2026	2.70	2.87	3.05
Mar 17, 2026	2.59	2.76	2.93
Mar 16, 2026	2.56	2.72	2.90
Mar 13, 2026	2.50	2.67	2.83
Mar 12, 2026	2.42	2.60	2.77
Mar 11, 2026	2.39	2.57	2.75
Mar 10, 2026	2.29	2.46	2.63

ALLO shares rose +5.80% in Tuesday, March 10, 2026's trading session, rising from a previous close of $2.50 to move at $2.65. The stock demonstrated notable intraday movement (see ALLO's key stats for a full breakdown), fluctuating between $2.53 and $2.71, a +7.11% trading range. While recent weeks have seen some volatility, ALLO has managed to secure a +29.02% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 5.6M shares changing hands, 1.51M more than the previous session. This amounted to $14.82M in total market activity.

Will ALLO Continue Its Upward Trend?

According to analyst ratings and projections for ALLO, Allogene Therapeutics, Inc. shares are anticipated to increase by +16.83%, potentially reaching $3.18 per share by March 23, 2026. Short-term technical indicators for ALLO currently suggest a bullish sentiment. This aligns with the stock's recent performance, as it has recorded 16 positive trading days within the past 30 sessions. Based on the ALLO stock forecast, now is a good time to buy ALLO stock because its current trading price is -12.35% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ALLO covering social and institutional perspectives.

ALLO Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ALLO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 64.48% to 65.78%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 61.57%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 57.23%, maintains a neutral outlook for the long term. Insights into ALLO's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Allogene Therapeutics Short-Term Forecasts

ALLO Forecast For Next 5 Days

Our algorithm anticipates Allogene Therapeutics (ALLO) stock could hit $2.44 by Mar 17, 2026. This represents a -7.78% fall from today's price, following a -5.99% change over the past five days.

ALLO Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Allogene Therapeutics, Inc. (ALLO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.55, which would mean a -3.59% decrease from the current price of $2.65. Projections for this period range from a high of $3.34 to a low of $2.01.

ALLO Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Allogene Therapeutics's price over the next three months point to a rise. ALLO stock is expected to peak at $10.28 on May 15, 2026 after potentially dipping to $7.28 on Apr 16, 2026. On average, ALLO is likely to trade around $8.88 in the coming 90 days.

Allogene Therapeutics Stock Forecast 2025

Based on our predictive models, Allogene Therapeutics (ALLO) is expected to trade between $5.31 and $18.17 throughout 2026. This would result in an average price of $10.71, potentially offering investors a +304.91% return from current levels.

Allogene Therapeutics, Inc. Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, Allogene Therapeutics, Inc. (ALLO) is positioned to show a strong performance in March 2026. The price is predicted to move between $7.83 and $8.95, settling at an average of $8.37. This could translate to a +216.45% gain.

April 2026

Based on current market signals, Allogene Therapeutics, Inc. is projected to trend april 2026. We forecast a trading range from $7.28 to $8.55, with a likely average price of $7.98. Investors could expect a potential return of +201.70%.

May 2026

Our predictive algorithms indicate Allogene Therapeutics, Inc. stock may see a shift in May 2026. The expected range spans $8.28–$10.28, with an average target of $9.78. This represents a positive outlook and a possible gain of +269.75%.

June 2026

Analyzing established trends, Allogene Therapeutics, Inc. looks set to move in June 2026. Projections place the stock between $8.41 and $10.23, averaging around $9.72. This suggests a +267.49% gain from current levels.

July 2026

Market indicators suggest Allogene Therapeutics, Inc. could experience notable changes during July 2026. Prices could fluctuate within $8.44 to $13.55, with a midpoint forecast of $11.27. The stock might deliver a +326.09% gain.

August 2026

Forecasting for August 2026, models estimate that Allogene Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $9.18 and $15.11, averaging $12.50. This signals a positive trajectory with potential returns around +372.59%.

September 2026

According to our latest forecast models, Allogene Therapeutics, Inc. (ALLO) is positioned to show a strong performance in September 2026. The price is predicted to move between $7.77 and $14.85, settling at an average of $12.05. This could translate to a +355.58% gain.

October 2026

Based on current market signals, Allogene Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $7.48 to $14.68, with a likely average price of $11.81. Investors could expect a potential return of +346.50%.

November 2026

Our predictive algorithms indicate Allogene Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $5.83–$17.64, with an average target of $11.84. This represents a positive outlook and a possible gain of +347.64%.

December 2026

Analyzing established trends, Allogene Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $5.31 and $18.17, averaging around $11.16. This suggests a +321.93% gain from current levels.

January 2027

Market indicators suggest Allogene Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $7.14 to $24.17, with a midpoint forecast of $15.61. The stock might deliver a +490.17% gain.

February 2027

Forecasting for February 2027, models estimate that Allogene Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $8.48 and $27.20, averaging $17.82. This signals a positive trajectory with potential returns around +573.72%.

March 2027

According to our latest forecast models, Allogene Therapeutics, Inc. (ALLO) is positioned to show a strong performance in March 2027. The price is predicted to move between $9.12 and $29.22, settling at an average of $19.12. This could translate to a +622.87% gain.

ALLO's history of dividends and stock splits also plays a role in long-term investor confidence.